Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Authors
Keywords
-
Journal
LANCET
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-08
DOI
10.1016/s0140-6736(21)00578-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Voclosporin: a novel calcineurin inhibitor without impact on mycophenolic acid in patients with SLE
- (2021) Teun van Gelder et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Update on Lupus Nephritis: Core Curriculum 2020
- (2020) Samir V. Parikh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression
- (2020) Anadi Mahajan et al. LUPUS
- Differential Effects of Voclosporin and Tacrolimus on Insulin Secretion From Human Islets
- (2020) Jelena Kolic et al. ENDOCRINOLOGY
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of standard of care treatment with a low steroid and mycophenolate mofetil regimen for lupus nephritis in the ALMS and AURA studies
- (2019) M Dall’Era et al. LUPUS
- Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis
- (2018) Julie E. Davidson et al. JOURNAL OF RHEUMATOLOGY
- A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
- (2018) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Multitarget Therapy for Induction Treatment of Lupus Nephritis
- (2015) Zhihong Liu et al. ANNALS OF INTERNAL MEDICINE
- Long-term follow-up of theMAINTAINNephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
- (2015) Farah Tamirou et al. ANNALS OF THE RHEUMATIC DISEASES
- Predictors of Long-Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro-Lupus Nephritis Cohort
- (2015) Maria Dall'Era et al. Arthritis & Rheumatology
- Prednisone in lupus nephritis: How much is enough?
- (2013) Guillermo Ruiz-Irastorza et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study
- (2012) S Wang et al. LUPUS
- The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation
- (2011) S. Busque et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis
- (2011) M Zeher et al. LUPUS
- Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis
- (2011) X. Li et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial
- (2010) Wei Chen et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study
- (2010) J. Zavada et al. LUPUS
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy
- (2008) H. Bao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
- (2008) Christian Faul et al. NATURE MEDICINE
- Value of a Complete or Partial Remission in Severe Lupus Nephritis
- (2007) Y. E. Chen et al. Clinical Journal of the American Society of Nephrology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started